| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 582 | 1,311 | 631 | 965 | | Cost of Revenue | 528 | 1,024 | 884 | 639 | | | Gross Profit | 54 | 287 | (253) | 326 | | | Operating Expenses | | Research Development | 3,425 | 1,361 | 2,253 | 2,086 | | Selling General and Administrative | 2,191 | 2,166 | 2,461 | 2,122 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,563) | (3,241) | (4,967) | (3,882) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 373 | 1,194 | 259 | 285 | | Earnings Before Interest And Taxes | (5,190) | (2,047) | (4,709) | (3,598) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,190) | (2,047) | (4,709) | (3,598) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (53) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,243) | (2,047) | (4,709) | (3,598) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,243) | (2,047) | (4,709) | (3,598) | | Preferred Stock And Other Adjustments | 51 | (51) |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,192) | ($2,098) | ($4,709) | ($3,598) |
|
0.11% Nasdaq 0.00%
Income Statement
